- Home
- THFF vs ABUS Comparison
THFF vs ABUS Comparison
Compare THFF & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- ABUS
- Stock Information
- Founded
- THFF 1984
- ABUS N/A
- Country
- THFF United States
- ABUS United States
- Employees
- THFF N/A
- ABUS N/A
- Industry
- THFF Major Banks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- ABUS Health Care
- Exchange
- THFF Nasdaq
- ABUS Nasdaq
- Market Cap
- THFF 599.3M
- ABUS 697.3M
- IPO Year
- THFF N/A
- ABUS N/A
- Fundamental
- Price
- THFF $46.61
- ABUS $3.21
- Analyst Decision
- THFF Hold
- ABUS Strong Buy
- Analyst Count
- THFF 1
- ABUS 4
- Target Price
- THFF $45.00
- ABUS $5.50
- AVG Volume (30 Days)
- THFF 52.5K
- ABUS 903.4K
- Earning Date
- THFF 01-28-2025
- ABUS 11-06-2024
- Dividend Yield
- THFF 3.86%
- ABUS N/A
- EPS Growth
- THFF N/A
- ABUS N/A
- EPS
- THFF 3.68
- ABUS N/A
- Revenue
- THFF $190,119,000.00
- ABUS $6,742,000.00
- Revenue This Year
- THFF N/A
- ABUS N/A
- Revenue Next Year
- THFF $12.01
- ABUS N/A
- P/E Ratio
- THFF $12.66
- ABUS N/A
- Revenue Growth
- THFF N/A
- ABUS N/A
- 52 Week Low
- THFF $34.58
- ABUS $2.21
- 52 Week High
- THFF $51.87
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- THFF 41.03
- ABUS 33.77
- Support Level
- THFF $45.58
- ABUS $3.13
- Resistance Level
- THFF $50.16
- ABUS $3.61
- Average True Range (ATR)
- THFF 1.40
- ABUS 0.17
- MACD
- THFF -0.59
- ABUS -0.03
- Stochastic Oscillator
- THFF 21.96
- ABUS 12.12
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.